BSE Live
Dec 02, 16:01Prev. Close
2229.90
Open Price
2230.15
Bid Price (Qty.)
2216.70 (18)
Offer Price (Qty.)
2226.85 (1)
NSE Live
Dec 02, 15:41Prev. Close
2229.80
Open Price
2240.10
Bid Price (Qty.)
2216.40 (32)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Mankind Pharma (in Rs. Cr.) | Mar 20 | |
| 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 1,437.74 | |
| Net CashFlow From Operating Activities | 1,069.71 | |
| Net Cash Used In Investing Activities | -439.16 | |
| Net Cash Used From Financing Activities | -530.74 | |
| Foreign Exchange Gains / Losses | 3.60 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 103.42 | |
| Cash And Cash Equivalents Begin of Year | 116.32 | |
| Cash And Cash Equivalents End Of Year | 219.73 |
12.11.2025
Mankind Pharma Standalone September 2025 Net Sales at Rs 2,608.78 crore, up 3.12% Y-o-Y
11.11.2025
07.11.2025
Mankind Pharma Consolidated September 2025 Net Sales at Rs 3,697.16 crore, up 20.17% Y-o-Y
07.11.2025
12.11.2025
Mankind Pharma Standalone September 2025 Net Sales at Rs 2,608.78 crore, up 3.12% Y-o-Y
07.11.2025
Mankind Pharma Consolidated September 2025 Net Sales at Rs 3,697.16 crore, up 20.17% Y-o-Y
01.08.2025
Mankind Pharma Consolidated June 2025 Net Sales at Rs 3,570.35 crore, up 23.4% Y-o-Y
01.08.2025
Mankind Pharma Standalone June 2025 Net Sales at Rs 2,541.36 crore, up 5.75% Y-o-Y